Sympathetic Blockade
Sympathetic Blockade is a pharmacological intervention that selectively inhibits the efferent activity of the sympathetic nervous system, thereby reducing vasomotor tone, heart rate, and myocardial contractility in the context of anesthesia-induced cardiovascular modulation.
1.4K
Publications
75K
Citations
4.9K
Authors
1.3K
Institutions
Publications per year
2017–2026
57
Variants
Sympathetic Nerve Blockade
1.4K
1–5 of 1.4K
4.9K
9
h-index
9
h-index
9
h-index
9
h-index
8
h-index
1–5 of 4.9K
1.3K

Sahlgrenska University Hospital
Gothenburg, Sweden
17 h-index
56 publications
3.4K citations

Karolinska Institutet
Stockholm, Sweden
17 h-index
40 publications
2.8K citations
Harvard University
Cambridge, United States
15 h-index
63 publications
5.7K citations

University of Gothenburg
Gothenburg, Sweden
14 h-index
39 publications
2K citations

Johns Hopkins University
Baltimore, United States
13 h-index
45 publications
3.3K citations

Wake Forest University
Winston-Salem, United States
13 h-index
53 publications
3.6K citations
University of Michigan
Ann Arbor, United States
13 h-index
67 publications
2.9K citations
Baker Heart and Diabetes Institute
Melbourne, Australia
12 h-index
48 publications
11.3K citations
1–8 of 1.3K
48 publications · 4.1K citations
36
h-index
43 publications · 5.9K citations
33
h-index
Repository · 95 publications · 3.3K citations
33
h-index
43 publications · 3.6K citations
31
h-index
56 publications · 2.2K citations
27
h-index
1–5